The investment objective of the Scheme is to provide returns before expenses that closely correspond to the total returns of the NIFTY Bank Index subject to tracking errors. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| ETFs | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -1.56% | -5.08% | -1.39% | -6.96% | -3.51% | 3.73% | 8.83% | 8.9% | 7.62% | N/A | 14.92% |
| Category returns | -2.99% | -4.52% | -3.02% | -5.03% | -4.77% | -2.03% | 9% | 10.98% | 7.45% | 11.5% | N/A |
| Absolute returns | -1.56% | -5.08% | -1.39% | -6.96% | -3.51% | 7.6% | 28.93% | 40.7% | 44.42% | N/A | 129.14% |
| Rank within category | 71/268 | 113/252 | 65/241 | 123/228 | 81/207 | 24/162 | 59/134 | 63/112 | 32/81 | N/A | N/A |
| ETFs | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Yearly returns | N/A | 14.09% | 21.78% | 13.07% | 6.05% | 17.85% | -6.48% |
| Q1 returns | N/A | 6.72% | 2.41% | -5.56% | -2.47% | 1.35% | -15.69% |
| Q2 returns | N/A | 4.7% | -7.63% | 10.8% | 11.69% | 11.6% | 14.9% |
| Q3 returns | N/A | 7.71% | 15.7% | -0.18% | 1.42% | -4.39% | -4.93% |
| Q4 returns | N/A | -5.19% | 11.26% | 8.25% | -4.01% | 8.98% | 1.55% |
| Alpha | -0.0167252 |
| Beta | 0.9991 |
| Sharpe Ratio | 0.0409141 |
| Sortino Ratio | 0.0705779 |
| R-Squared | 0.9973 |
| Tracking Error | 0.0302 |
| Downside Risk | 23.5686 |
| Std. Deviation (Annualised) | 15.0144 |
| ETFs | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | -7.16% | -4.01% | 10.11% | 12.75% | 6.7% | 19.48% | N/A | N/A | 19.41% | 44.40 | 0.36 | 0.30 | Very High |
| Nippon India Nifty Pharma ETF | -4.12% | -0.09% | 14.11% | 16.17% | 15.52% | 19.28% | 12.79% | N/A | 12.07% | 1,736.44 | 0.23 | 0.30 | Very High |
| Motilal Oswal BSE Enhanced Value ETF | -3.37% | -6.03% | -9.38% | -9.5% | -0.01% | 18.7% | N/A | N/A | 26.28% | 146.61 | 0.43 | 0.20 | Very High |
| DSP Nifty PSU Bank ETF | -0.29% | -1.08% | -5.84% | -7.11% | 9.24% | 18.66% | N/A | N/A | 20.49% | 1,434.17 | 0.16 | 0.15 | Very High |
| ICICI Prudential Nifty PSU Bank ETF | -0.32% | -1.15% | -6.01% | -7.33% | 8.91% | 18.53% | N/A | N/A | 26.2% | 118.61 | 0.41 | 0.15 | Very High |
| Nippon India ETF Nifty PSU Bank BeES | -0.32% | -1.17% | -6.04% | -7.39% | 8.81% | 18.35% | 25.56% | 10.01% | 6.93% | 3,932.00 | 0.51 | 0.14 | Very High |
| Kotak Nifty PSU Bank ETF | -0.32% | -1.17% | -6.06% | -7.4% | 8.79% | 18.33% | 25.56% | 9.94% | 6.36% | 2,490.74 | 0.51 | 0.14 | Very High |
| Aditya Birla Sun Life Nifty Healthcare ETF | -6.38% | -4.45% | 7.53% | 9.15% | 4.95% | 18.01% | 0% | N/A | 12.85% | 74.67 | 0.20 | 0.27 | Very High |
| ICICI Prudential Nifty Healthcare ETF | -6.38% | -4.44% | 7.56% | 9.19% | 5% | 17.87% | 12.38% | N/A | 12.86% | 231.43 | 0.16 | 0.27 | Very High |
| Axis NIFTY Bank ETF Current | -1.56% | -5.08% | -1.39% | -6.96% | -3.51% | 8.83% | 7.62% | N/A | 14.92% | 292.62 | 0.25 | 0.04 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| HDFC Bank Ltd. | Banks | Domestic Equities | 18.61% |
| ICICI Bank Ltd. | Banks | Domestic Equities | 14.18% |
| Kotak Mahindra Bank Ltd. | Banks | Domestic Equities | 10.20% |
| Axis Bank Ltd. | Banks | Domestic Equities | 10.06% |
| State Bank Of India | Banks | Domestic Equities | 9.93% |
| The Federal Bank Ltd. | Banks | Domestic Equities | 6.56% |
| IndusInd Bank Ltd. | Banks | Domestic Equities | 4.97% |
| AU Small Finance Bank Ltd. | Banks | Domestic Equities | 4.85% |
| IDFC First Bank Ltd. | Banks | Domestic Equities | 4.54% |
| Bank Of Baroda | Banks | Domestic Equities | 3.59% |
| Canara Bank | Banks | Domestic Equities | 3.37% |
| Punjab National Bank | Banks | Domestic Equities | 3.27% |
| Yes Bank Ltd. | Banks | Domestic Equities | 3.01% |
| Union Bank Of India | Banks | Domestic Equities | 2.86% |
| Clearing Corporation of India Ltd | Cash & Cash Equivalents and Net Assets | 0.11% | |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | -0.11% | |
| Total | 100.00% | ||
andik is a seasoned financial services professional with over two decades of experience, predominantly in the asset management space. Prior to joining Axis AMC, he was the Chief Investment Officer (CIO) at Avendus Capital Public Markets Alternate Strategies LLP. Notably, Nandik also led the successful launch of the Long Short Fund at ICICI Prudential AMC, further cementing his expertise in innovative investment strategies.Educational Qualification: PGDM in Finance from IIM Calcutta, Master's Degree in Finance from London Business School, and BTech from IIT Kharagpur.
Mr. Rohit Kumar Gautam has an experience of over 13 years in his professional career. He joined as the "Head Research" in Shriram Asset Management Company Limited in June, 2019. Prior to joining Shriram, he was associated with APRRUS Foods and Beverages Pvt. Ltd., Firestar International Pvt. Ltd., Pythhos Technology Pvt. Ltd./Boston Analytics, Hangout Adventures where he had held various key positions in Research & Analysis, Corporate Strategy & Planning Professional, etc.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
